Roberts Zachary

Track

Insider profile

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return -31% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Roberts Zachary's trades of Allogene Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
348.01
Quantity 22,609
Value US$3,842,580
Transaction date
Proposed sale
Price
1.56
Quantity 26,269
Value US$40,929
Transaction date
Proposed sale
Price
1.70
Quantity 18,832
Value US$32,014
Transaction date
Proposed sale
Price
1.78
Quantity 27,199
Value US$48,499
Transaction date
Proposed sale
Price
3.17
Quantity 24,690
Value US$78,376
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-04 2026-02-02
S Sale
79,086 +5.2%
140.83
US$112,727 		79,086 +5.2% 140.83 US$112,727
2026-02-02 2026-02-02
PrS Proposed sale
22,609
348.01
US$3,842,580 		22,609 348.01 US$3,842,580
2026-01-23 2026-01-21
S Sale
63,104 +43.0%
111.49
US$2,593,618 		63,104 +43.0% 111.49 US$2,593,618
2026-01-21 2026-01-21
PrS Proposed sale
26,269
1.56
US$40,929 		26,269 1.56 US$40,929
2025-02-05 2025-02-03
S Sale
18,832 -2.8%
1.70
US$32,014 		18,832 -2.8% 1.70 US$32,014
2025-02-03 2025-02-03
PrS Proposed sale
18,832
1.70
US$32,014 		18,832 1.70 US$32,014
2025-01-23 2025-01-21
S Sale
27,199 -5.3%
1.78
US$48,414 		27,199 -5.3% 1.78 US$48,414
2025-01-21 2025-01-21
PrS Proposed sale
27,199
1.78
US$48,499 		27,199 1.78 US$48,499
2024-01-22 2024-01-22
PrS Proposed sale
24,690
3.17
US$78,376 		24,690 3.17 US$78,376